MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
The COVID-19 Storm and Rebooting Interventional Cardiology After the First Wave
Lessons learned from Spain.
By Rafael Romaguera, MD, PhD; Raul Moreno, MD, PhD; Ignacio Cruz, MD, PhD; and Jose M. de la Torre Hernandez, MD, PhD
SUGAR Trial Compares DES in Treating Patients With Diabetes Undergoing PCI
November 4, 2021—Results from SUGAR, a randomized, controlled, multicenter trial conducted exclusively in patients with diabetes mellitus (DM) and with minimum exclusion criteria, found that amphilimus-eluting stents (AES) were superior to zotarolimus-eluting stents (ZES) regarding target lesion and target vessel failure composite outcomes at 1 year.
